Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 Mar 24;18(4):1070–1076. doi: 10.1158/1055-9965.EPI-08-0707

Table 1.

Selected characteristics of SCC cases by age at diagnosis*

22–35 years old n=165
36–53 years old n=168
Characteristic Frequency % Frequency %
Age (years)
 Mean (standard deviation) 31.0 (3.2) 41.1 (4.0)
 Median 32 40
Birth year
 1951–1959 73 44 120 71
 1960–1967 92 56 48 29
Race
 White 152 92 143 85
 Non-White 13 8 25 15
Education
 High school or less 74 45 62 37
 More than high school 91 55 106 63
Income
 Less than $30,000 per year 93 57 64 39
 $30,000 per year or more 71 43 100 61
 Unknown 1 4
Marital status
 Never married 27 16 21 13
 Ever married 138 84 147 88
Cigarette smoking
 Never 49 30 74 44
 Former 48 29 33 20
 Current 68 41 61 36
Age at menses (years)
 Less than 12 32 19 34 20
 12 to 13 80 48 94 56
 14 or older 53 32 40 24
Combined OC use
 Never to <6 months 29 18 52 31
 6 months to < 5 years 57 35 59 35
 5 or more years 79 48 57 34
Number of full term pregnancies
 0 46 28 30 18
 1 41 25 30 18
 2 or more 78 47 108 64
Full term pregnancy rate
 None 18 11 15 9
 < 1 per 10 years 29 18 57 34
 1 per 10 to <2 per 10 years 55 34 61 37
 2 per 10 years or greater 62 38 34 20
Pap frequency in most recent decade
 None 7 4 2 1
 1 to 5 per decade 67 41 102 63
 6 to 8 per decade 10 6 15 9
 1 per year 61 37 34 21
 Greater than 1 per year 19 12 10 6
 Unknown 1 5
Lifetime number of sex partners
 1 5 3 11 7
 2 to 4 46 28 52 31
 5 to 14 74 45 69 41
 15 or more 40 24 35 21
 Unknown 0 1
Chlamydia trachomatis serology§
 Negative 45 52 26 58
 Positive 41 48 19 42
 Test not performed or unknown 79 123
HSV-2 serology §
 Negative 79 56 34 47
 Positive 61 44 39 53
 Test not performed or unknown 25 95
FIGO Stage
 Stage 1 151 92 131 81
 Stage 2–4 13 8 30 19
 Unknown 1 7
HPV DNA results
 HPV negative 14 11 9 9
 HPV-16 positive 88 71 60 62
 HPV-18 positive 8 6 10 10
 HPV-16 and -18 positive 6 5 9 9
 HPV positive for other types** 8 6 9 9
 HPV positive, type unknown 3 0
 Insufficient sample 8 3
 Test not performed or unknown 30 68
HPV 16/18 serology
 HPV-16 and -18 negative 80 56 30 42
 Only HPV-16 positive 29 20 14 19
 Only HPV-18 positive 13 9 16 22
 HPV-16 and -18 positive 20 14 12 17
 Test not performed or unknown 23 96
*

SCC= squamous cell cervical cancer, HSV-2=Herpes simplex virus type 2, FIGO=International Federation of Gynecology, and Obstetrics (FIGO), HPV=Human papillomavirus

Unless otherwise indicated

Includes currently or formerly married or lived with a partner for greater than 6 months

§

Chlamydia trachomatis, HSV-2, HPV-16 and HPV-18 serology only available on cases enrolled prior to 1999, which excludes 94 cases (88 diagnosed at 36–53 years of age and 8 diagnosed at 22–36 years of age)

**

Includes HPV types 6, 31, 33, 45, 53, 58, and/or 73